BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 4, 2001
View Archived Issues
AstraZeneca does not exercise option for TAPET-CPG2
Read More
Vernalis makes significant progress during past year
Read More
MabCampath recommended for approval in the E.U.
Read More
Sepracor submits sNDA to FDA for pediatric use of Xopenex
Read More
SBL Vaccin to distribute, market Aventis Pasteur vaccines in Sweden
Read More
NZ-1001 restores normal skeletal muscle function in mouse model
Read More
FDA extends review period for Xyrem
Read More
Telik moves TLK-286 to phase II
Read More
ID Biomedical begins purchase of Intellivax
Read More
Travatan launch quickly follows first approval in U.S.
Read More
MEDI-507 enters phase II evaluation in patients with psoriasis
Read More
Ligand updates Targretin developments in the E.U.
Read More
Nonopioid DOP agonists presented at ACS meeting by Pfizer group
Read More
Canadian regulatory approval obtained for new HIV protease inhibitor combination
Read More
Phase II studies commence for Titan's gallium formulation
Read More
Twinstrand takes a novel approach to cancer treatment, as reported at AACR meeting
Read More
Drug candidate for diabetic complications emerges from R&D at Dynamis
Read More
Imidazoline-based alpha1A-selective compounds from GSK targeted for urinary incontinence
Read More
Two series of antitumor agents prepared and tested at Lafon
Read More
New matrix metalloproteinase inhibitors and potential uses claimed by former Warner-Lambert
Read More
Spirocyclic sigma receptor ligands in the Sepracor pipeline
Read More
Southern Research Institute presents preparation and uses of new compounds derived from naltrexone
Read More
Cell adhesion inhibitors identified by Merck group
Read More
Selective Y5 receptor antagonists characterized at GSK, useful as pharmacological tools
Read More
Kikkoman discloses new series of selective alpha-glucosidase inhibitors
Read More
New PKC activators useful for ocular hypertension, glaucoma, etc.
Read More
Putative TPO receptor modulator discovered by Receptron scientists enters phase I
Read More